Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct that was used to make the CAR T cells was unrelated to the second tumor.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology